News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi (France) (SAN.PA) Sues Eli Lilly and Company (LLY) Over Insulin Rival To Lantus


7/9/2014 7:22:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Sanofi SA, whose top-selling Lantus helps diabetics control blood sugar levels, has filed a lawsuit accusing Eli Lilly and Co of infringing seven patents related to insulin and devices used to deliver it.

Through its complaint made public on Tuesday in the U.S. District Court in Wilmington, Delaware, Sanofi is seeking to halt Lilly's proposed commercial marketing in the United States of a rival treatment, known as Abasria, saying the sale would violate its rights.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at News Release
Read at EconomicTimes

comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES